Sanuwave records Q4 revenue $13.4M (+29.7% YoY); FY rev $44.1M; guides FY26 $51-55M

SANUWAVE Health, Inc.

Q4 2025 revenue record $13.4M (+29.7% YoY); FY 2025 revenue record $44.1M (+35% YoY).
GAAP operating income $2.0M Q4 ($4.9M FY); net income $7.7M Q4 vs loss $13.3M Q4 2024.
Adjusted EBITDA Q4 $4.8M vs $3.7M YoY; FY $13.6M vs $7.2M YoY.
Guides Q1 2026 rev $9.6-10.3M (+3-10%); FY 2026 rev $51-55M (+16-25% vs FY25).
Sold 255 UltraMist systems in Q4 (up from 135); consumables rev +10.6% to $6.5M.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

SANUWAVE Health, Inc. reported the fourth quarter and fiscal year ended December 31, 2025 results: revenue $13.4 million, net income $7.7 million. Guidance initiated.

Period: the fourth quarter and fiscal year ended December 31, 2025
Revenue: $13.4 million
Net income: $7.7 million
Guidance: initiated
Result: reported results

Exact text from the filing

forth by specific reference in such filing. --- EX-99.1 (EX-99.1) --- Sanuwave Announces Record Revenues and Financial Results for Q4 and Full Year 2025 Q4 2025 revenues were $13.4 million, up 29.7% from Q4 2024. This was an all-time quarterly record for the Company. Full year 2025 revenues were $44.1 million up 35.0% from full year 2024 revenues. This was an

View on SEC.gov

1362 earnings releases filed in the last 30 days. Browse all earnings releases →

SANUWAVE Health, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-021464

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.